UT Austin Researchers Use AI to Find Monkeypox Drug Target
AI modeling identifies a viral protein vulnerability, accelerating vaccine development.
A Breakthrough in Viral Defense
Researchers at the University of Texas at Austin published findings in Science Translational Medicine detailing how artificial intelligence helped identify a new vulnerability in the Monkeypox virus (MPXV). The discovery offers a promising path for developing more effective vaccines and antibody therapies.
Accelerating Discovery
The research team used AlphaFold-derived tools to predict the structure of viral surface proteins that were previously poorly understood. - Precision Targeting: The AI model identified a specific protein that, when targeted by antibodies in mouse models, successfully neutralized the virus. - Speed: Lead researcher Jason McLellan noted that …
Archive Access
This article is older than 24 hours. Create a free account to access our 7-day archive.